Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28288104 | 0.89 | CCR1 (0.40) | RAB9ACCR1CCR5CCR8HDAC6 | |
| SCHEMBL30888429 | 0.89 | CCR1 (0.40) | RAB9ACCR1CCR5CCR8HDAC6 | |
| SCHEMBL1549465 | 0.84 | GRM2 (0.50) | KDM4EGRM2RAB9ACASP3 | |
| SCHEMBL21035108 | 0.84 | CNR2 (0.44) | KDM4EGRM2CNR2RAB9A | |
| SCHEMBL197456 | 0.82 | CCR1 (0.46) | GRM5CNR2CASP3CCR1CCR5 | |
| SCHEMBL31504098 | 0.82 | CCR1 (0.46) | GRM5CNR2CASP3CCR1CCR5 | |
| Hydrochloric Acid SCHEMBL7040410 | 0.75 | KDM4E (0.52) | KDM4ERAB9ACCR1CCR5CCR8 | |
| SCHEMBL2411349 | 0.73 | CYP11B1 (0.59) | RAB9A | |
| SCHEMBL17799 | 0.73 | — | — | |
| SCHEMBL21873406 | 0.72 | KMT2A (0.39) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019104011-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2019-05-31 | — | — | WO | disclosed |